RegenLab
Latest Papers

A paper showing that microglia influence neuronal autophagy

2023-04-27

The paper introduced this time is here.

Microglial-to-neuronal CCR5 signaling regulates autophagy in neurodegeneration

B. P. Festa, F. H. Siddiqi, M. Jimenez-Sanchez, H. Won, M. Rob, A. Djajadikerta, et al.

Neuron 2023

DOI: 10.1016/j.neuron.2023.04.006

Just a moment…

www.cell.com

A simple explanation…

How was the experiment carried out?

This is an animal experiment using mice.

The methods used in this paper included:

Autophagy flux is an indicator showing the entire process of autophagy, and is used to evaluate the dynamics of the breakdown and recycling of intracellular materials by autophagy. Autophagy is a physiological process in which, under stress conditions or during nutrient deficiency, cells break down and recycle unnecessary or damaged intracellular structures and proteins, thereby reusing energy and components.

Autophagy consists of the following main steps.

  1. Formation of the autophagosome: a double-membrane structure that engulfs intracellular proteins and organelles is formed.
  2. Fusion with the lysosome: the autophagosome fuses with the lysosome to form an autophagic lysosome (autolysosome).
  3. Breakdown and recycling: within the autophagic lysosome, the contents are broken down by lysosomal enzymes, and their components are reused inside the cell.

Autophagy flux can measure the activity and efficiency of autophagy by evaluating the series of processes from the formation of the autophagosome to breakdown and recycling. Methods such as fluorescent labeling of proteins, Western blotting, and gene expression analysis are used to evaluate autophagy flux.

What kind of results were obtained?

The results of this study found that activated microglia inhibit neuronal autophagy that is harmful to neurons. In this study, microglia-derived CCL-5/-4/-3 activated neuronal CCR5 to inhibit neuronal autophagy. The researchers also found that CCR5 and CCL-3/-4/-5 are increased in the brains of mice with Huntington’s disease and tauopathy, indicating that this pathway may be involved in the pathogenesis of these diseases.

Furthermore, in this study, it was found that administering a drug that inhibits CCR5 prevented mTORC1 activation, the decrease of LC3-II, and the accumulation of mHTT in HeLa CCR5-GFP cells, suggesting that targeting this pathway may become a potential therapeutic strategy for neurodegenerative diseases.

What is the future of this research?

Possible directions include investigating the role of CCR5 in other neurodegenerative diseases, identifying other factors that regulate neuronal autophagy, and exploring the possibility of targeting this pathway as a therapeutic strategy for neurodegenerative diseases.

It suggests that further research is needed to determine whether this finding can be applied clinically.

Impressions

Autophagy is an extremely important mechanism in tissue repair. I am very interested in the involvement of this autophagy in stem cell therapy and exosome therapy as well. I think I will continue to study it further.

English Abstract

Microglia-to-neuronal CCR5 signaling regulates autophagy in neurodegeneration

In neurodegeneration diseases, microglia switch to an activated state, which results in excessive secretion of pro-inflammatory factors. Our work aims to investigate how this paracrine signaling affects neuronal function. Here, we show that activated microglia mediate non-cell-autonomous inhibition of neuronal autophagy, a degenerative pathway critical for removal toxic, aggregate-prompt proteins accumulating in neurodegenerative disease. We found that the microglia-derived CCL-3/-4/-5 bind and activate neural CCR5, which in turn promotes mTORC1 activation and disrupts autophagy and aggregate-protein clearance. CCR5 and its cognate chemokines are upregulated in the brains of pre-manifesting mouse models for Huntington’s disease (HD) and tauopathy, suggesting a pathological role of this microglia-neuronal axis in the early phase of these disease. CCR5 upregulation is self-sustaining, as CCL5-CCR5 autophagy inhibition impairs CCR5 degradation itself. Finally, pharmacological or genetic inhibition of CCR5 rescues mTORC1 hyperactivation and autophagy dysfunction, which ameliorates HD and tau pathologies in mouse models.

2.62531017